This formulation combines Tesamorelin, a synthetic analog of growth hormonereleasing hormone (GHRH), and Ipamorelin, a selective growth hormone secretagogue, both of which are commonly examined in laboratory environments for their influence on endocrine signaling pathways related to growth hormone regulation
The Precision Peptide Genetic Test analyzes key variants including which influences GLP-1 receptor sensitivity, and MC4R rs17782313, which affects appetite regulation pathways
Yet, it is unknown if this formulation would exert primarily local effects on the digestive system, or if it would work systemically
There is no specific GLP-1 drug that has been shown to have the least adverse effects, as sensitivity varies between individuals
Lipohypertrophy changes how the peptide absorbs, creating unpredictable blood levels and inconsistent results